These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25846334)

  • 21. Development of Escherichia coli MG1655 strains to produce long chain fatty acids by engineering fatty acid synthesis (FAS) metabolism.
    Jeon E; Lee S; Won JI; Han SO; Kim J; Lee J
    Enzyme Microb Technol; 2011 Jun; 49(1):44-51. PubMed ID: 22112270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Techniques for chromosomal integration and expression optimization in Escherichia coli.
    Ou B; Garcia C; Wang Y; Zhang W; Zhu G
    Biotechnol Bioeng; 2018 Oct; 115(10):2467-2478. PubMed ID: 29981268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic engineering of Escherichia coli to produce gamma-aminobutyric acid using xylose.
    Zhao A; Hu X; Wang X
    Appl Microbiol Biotechnol; 2017 May; 101(9):3587-3603. PubMed ID: 28190099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic engineering of Escherichia coli for the production of fumaric acid.
    Song CW; Kim DI; Choi S; Jang JW; Lee SY
    Biotechnol Bioeng; 2013 Jul; 110(7):2025-34. PubMed ID: 23436277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assembly and multiple gene expression of thermophilic enzymes in Escherichia coli for in vitro metabolic engineering.
    Ninh PH; Honda K; Sakai T; Okano K; Ohtake H
    Biotechnol Bioeng; 2015 Jan; 112(1):189-96. PubMed ID: 25065559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production of 3-O-xylosyl quercetin in Escherichia coli.
    Pandey RP; Malla S; Simkhada D; Kim BG; Sohng JK
    Appl Microbiol Biotechnol; 2013 Mar; 97(5):1889-901. PubMed ID: 23053089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recruiting alternative glucose utilization pathways for improving succinate production.
    Tang J; Zhu X; Lu J; Liu P; Xu H; Tan Z; Zhang X
    Appl Microbiol Biotechnol; 2013 Mar; 97(6):2513-20. PubMed ID: 22895848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Designing and producing modified, new-to-nature peptides with antimicrobial activity by use of a combination of various lantibiotic modification enzymes.
    van Heel AJ; Mu D; Montalbán-López M; Hendriks D; Kuipers OP
    ACS Synth Biol; 2013 Jul; 2(7):397-404. PubMed ID: 23654279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterologous production of ribostamycin derivatives in engineered Escherichia coli.
    Kurumbang NP; Park JW; Yoon YJ; Liou K; Sohng JK
    Res Microbiol; 2010 Sep; 161(7):526-33. PubMed ID: 20561584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction of a new shuttle vector and its use for cloning and expression of two plasmid-encoded bacteriocins from Lactobacillus paracasei subsp. paracasei BGSJ2-8.
    Kojic M; Lozo J; Jovcic B; Strahinic I; Fira D; Topisirovic L
    Int J Food Microbiol; 2010 Jun; 140(2-3):117-24. PubMed ID: 20439125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing the potential of the two-peptide lantibiotic lichenicidin as a new generation antimicrobial.
    Barbosa JC; Silva ÍC; Caetano T; Mösker E; Seidel M; Lourenço J; Süssmuth RD; Santos NC; Gonçalves S; Mendo S
    World J Microbiol Biotechnol; 2022 Jan; 38(1):18. PubMed ID: 34977979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engineered short branched-chain acyl-CoA synthesis in E. coli and acylation of chloramphenicol to branched-chain derivatives.
    Bi H; Bai Y; Cai T; Zhuang Y; Liang X; Zhang X; Liu T; Ma Y
    Appl Microbiol Biotechnol; 2013 Dec; 97(24):10339-48. PubMed ID: 24100682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biosynthesis of butenoic acid through fatty acid biosynthesis pathway in Escherichia coli.
    Liu X; Yu H; Jiang X; Ai G; Yu B; Zhu K
    Appl Microbiol Biotechnol; 2015 Feb; 99(4):1795-804. PubMed ID: 25472435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Escherichia coli for biofuel production: bridging the gap from promise to practice.
    Huffer S; Roche CM; Blanch HW; Clark DS
    Trends Biotechnol; 2012 Oct; 30(10):538-45. PubMed ID: 22921756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction and performance of heterologous polyketide-producing K-12- and B-derived Escherichia coli.
    Wu J; Boghigian BA; Myint M; Zhang H; Zhang S; Pfeifer BA
    Lett Appl Microbiol; 2010 Aug; 51(2):196-204. PubMed ID: 20565574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insights into the mode of action of the two-peptide lantibiotic lichenicidin.
    Barbosa JC; Gonçalves S; Makowski M; Silva ÍC; Caetano T; Schneider T; Mösker E; Süssmuth RD; Santos NC; Mendo S
    Colloids Surf B Biointerfaces; 2022 Mar; 211():112308. PubMed ID: 34973602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advanced technologies for improved expression of recombinant proteins in bacteria: perspectives and applications.
    Gupta SK; Shukla P
    Crit Rev Biotechnol; 2016 Dec; 36(6):1089-1098. PubMed ID: 26384140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significantly enhanced production of isoprene by ordered coexpression of genes dxs, dxr, and idi in Escherichia coli.
    Lv X; Xu H; Yu H
    Appl Microbiol Biotechnol; 2013 Mar; 97(6):2357-65. PubMed ID: 23143466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic engineering of Escherichia coli to improve recombinant protein production.
    Liu M; Feng X; Ding Y; Zhao G; Liu H; Xian M
    Appl Microbiol Biotechnol; 2015 Dec; 99(24):10367-77. PubMed ID: 26399416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A versatile system for the expression of nonmodified bacteriocins in Escherichia coli.
    Ingham AB; Sproat KW; Tizard ML; Moore RJ
    J Appl Microbiol; 2005; 98(3):676-83. PubMed ID: 15715871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.